Chargement en cours...

Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer

BACKGROUND: Metastatic colorectal cancer (mCRC) is a heterogeneous disease. Predictive biomarkers are in great demand to optimize patient selection at high risk for death and to provide a novel insight into potential targeted therapy. METHODS: The present study retrospectively analyzed the gene expr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Transl Med
Auteurs principaux: Ye, Shu-Biao, Cheng, Yi-Kan, Hu, Jian-Cong, Gao, Feng, Lan, Ping
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049050/
https://ncbi.nlm.nih.gov/pubmed/32175389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.12.112
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!